HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Steven Grant, M.D., in the laboratory

Steven Grant, M.D., in the laboratory

NCATS announced nearly $3 million to fund four drug repurposing projects aimed at finding therapies for type 2 diabetes, glioblastoma, acute myeloid leukemia and Chagas disease.

A medical worker prepares to vaccinate a young boy.

News Brief: NCATS-FDA Team Receives HHS Innovation Ventures Support to Crowdsource Information on Treating Tropical Diseases

Researchers will enhance the Web-based Collaborative Use Repurposing Engine, which enables the crowdsourcing of medical information.

Postdoctoral fellows in an NCATS laboratory

Partnering with Disease Foundations to Speed Drug Discovery

NCATS’ postdoctoral fellows with disease expertise receive training in early drug discovery.

Very high magnification micrograph of an ovarian clear cell carcinoma. (Credit: http://bit.ly/1GXE2mc. Copyright: http://bit.ly/1fd019p)

Stopping Metastasis in Its Tracks: New 3-D Cell Model Enables Closer Look at Cancer Progression

NCATS and University of Chicago researchers have developed a 3-D model of ovarian cancer metastasis using cells from patients to help identify potential therapeutic compounds.

NCATS e-newsletter and a coffee cup on a table

NCATS e-newsletter

Learn more about awards to repurpose drugs for new therapeutic uses, new leadership in the NCATS Executive Office and more.

New Therapeutic Uses Awards

NCATS announced nearly $3 million to fund four drug repurposing projects aimed at finding therapies for type 2 diabetes, glioblastoma, acute myeloid leukemia and Chagas disease.

Steven Grant, M.D., in the laboratory

July E-Newsletter Now Available

Learn more about awards to repurpose drugs for new therapeutic uses, new leadership in the NCATS Executive Office and more.

NCATS e-newsletter and a coffee cup on a table

NCATS-FDA Team Receives HHS Innovation Ventures Support

Researchers will enhance the Web-based Collaborative Use Repurposing Engine, which enables the crowdsourcing of medical information.

A medical worker prepares to vaccinate a young boy.

Partnering with Disease Foundations to Speed Drug Discovery

NCATS’ postdoctoral fellows with disease expertise receive training in early drug discovery.

Postdoctoral fellows in an NCATS laboratory

3-D Cell Model Enables Closer Look at Cancer Progression

NCATS and University of Chicago researchers have developed a 3-D model of ovarian cancer metastasis using cells from patients to help identify potential therapeutic compounds.

Very high magnification micrograph of an ovarian clear cell carcinoma. (Credit: http://bit.ly/1GXE2mc. Copyright: http://bit.ly/1fd019p)

More Center News

Keith LamirandeExecutive Officer Announced
Keith Lamirande named associate director for administration, will lead NCATS Executive Office.

Laboratory equipmentSBIR/STTR Omnibus Solicitation
Small businesses are encouraged to apply for NCATS grant support by Sept. 8, 2015.

  • Facebook icon
  • Twitter icon
  • YouTube icon

Director's Corner

Meet Chip

Tissue Chip for Drug Screening (Chip)

Explore this interactive model of the innovative advances from the NCATS-supported Tissue Chip for Drug Screening program. Are you ready to Meet Chip?

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.